This research was funded by a grant from Biogen. This research was approved by the University of South Florida Institutional Review Board.
Conflict of Interest
Derrick Robertson is a consultant for Alexion, Biogen, Celgene, EMD Serono, Genentech, Novartis, Sanofi-Genzyme, and Teva Neuroscience; is on a speaker bureau for Acorda, Alexion, Biogen, Celgene, EMD Serono, Genentech, Mallinckrodt, Novartis, Sanofi-Genzyme, and Teva Neuroscience; and has received grant support from Actelion, Biogen, EMD Serono, Genentech, Medimmune, Mallinckrodt, MedDay, Novartis, PCORI, Sanofi-Genzyme, and TG Therapeutics. Lise Casady is on a speaker bureau and consults for Genentech, Sanofi-Genzyme, and Biogen. Janice Maldonado has received grant support from Genentech and Medimmune. Natalie Moreo, Crystal Dixon, Laurie Pearsall, and Angela Aungst have no conflicts of interest that are directly relevant to the content of this article.
All procedures in this study were in accordance with the 1964 Helsinki Declaration including amendments and with the oversight of the University of South Florida Institutional Review Board that approved the study.
Written informed consent was obtained from all patients who participated in this study.